Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/4/2026

Oral Corticosteroids Are Not Recommended for Lumbar Radiculopathy

Lack of Efficacy of Systemic Corticosteroids

  • The American College of Physicians advises that systemic corticosteroids should not be used for low‑back pain with or without sciatica because consistent evidence shows no pain‑relieving benefit. Moderate‑strength evidence supports this recommendation. 1
  • Six randomized trials (moderate‑strength evidence) found no difference in pain relief between systemic corticosteroids and placebo for radicular low‑back pain. 2
  • Multiple high‑quality guidelines and trials (including two Annals of Internal Medicine publications) demonstrate that a short course of oral corticosteroids provides no clinically meaningful benefit over placebo for lumbar radiculopathy pain. High‑quality evidence. 1, 2

First‑Line (NSAIDs) – cited indirectly, no citation, so omitted.

Second‑Line: Adding Gabapentin

  • Combining an NSAID with gabapentin targets both inflammatory and neuropathic components of radiculopathy. Fair evidence for this combination. 1
  • Gabapentin alone has fair evidence of modest, short‑term effectiveness specifically for radiculopathy, though the benefit size is small. 1, 3

Third‑Line: Skeletal Muscle Relaxants (when muscle spasm is prominent)

  • Adding a skeletal muscle relaxant to the NSAID regimen can provide short‑term pain relief in patients with prominent muscle spasm. Fair evidence. 3
  • Sedation is a common adverse effect of skeletal muscle relaxants, occurring in most patients. Moderate‑strength evidence. 2, 3

Corticosteroid Use in Back Pain and Sciatica

Evidence Against Corticosteroid Use

  • The American College of Physicians and American Pain Society guidelines explicitly state that systemic corticosteroids should not be used for low back pain with or without sciatica based on consistent evidence showing lack of efficacy 4
  • Three high-quality trials consistently demonstrated no clinically significant benefit when systemic corticosteroids were given either parenterally or as a short oral taper for acute sciatica 5, 6, 7, 8
  • For acute low back pain without radiculopathy, a single intramuscular injection of methylprednisolone showed no difference in pain relief through 1 month compared to placebo 5, 6

Safety Considerations

  • Short courses of corticosteroids do not appear to cause serious harms, though adverse events are more common than placebo 6, 5
  • Hyperglycemia, facial flushing, and gastrointestinal effects can occur but are generally transient with short courses 5, 6
  • First-line treatment should be NSAIDs, not corticosteroids, as NSAIDs provide small to moderate improvements in pain intensity for acute low back pain 9
  • NSAIDs combined with gabapentin target both inflammatory and neuropathic components for radicular pain specifically 10
  • Advise patients to remain active and avoid bed rest, as activity restriction delays recovery 9

Critical Pitfall to Avoid

  • Clinical trials consistently show that corticosteroids do not provide meaningful pain relief for sciatica despite their anti-inflammatory properties 4, 5, 6

REFERENCES

9

Treatment of Acute Low Back Pain [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

10

Gabapentin for Spinal Stenosis Pain and Radiculopathy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025